Clinical Trials Browser

Phase 1/2 × Withdrawn × PM 01183 × Clear all

NCT06385548 2025-04-01

LiDer

Phase 1/2 Withdrawn

Endometrial Neoplasms

NCT05042934 2022-02-10

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Phase 1/2 Withdrawn

Sarcoma, Ewing